Cell Signaling Technology Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cell Signaling Technology Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10286
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cell Signaling Technology Inc (CST) is a biological research and diagnostic products provider. The company offers primary antibodies, antibody samplers, secondary antibodies, antibody conjugates, elisa kits, chip kits and reagents proteomic analysis products, cellular assay kits, WB and IP reagents, sirna, activators and inhibitors, experimental controls and buffers and dyes. It provides services such as customized solutions, proteomics services and custom antibody conjugation. CST offers research programs on pathway research, PTM data base, cancer research, protein kinases and cellular landscapes. The company has its presence in the Austria, Belgium, Germany, Netherlands, China and Japan. CST is headquartered in Danvers, Massachusetts, the US.

Cell Signaling Technology Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cell Signaling Technology Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cell Signaling Technology Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cell Signaling Technology Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cell Signaling Technology Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cell Signaling Technology Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cell Signaling Technology Inc, Medical Equipment, Deal Details 10
Partnerships 10
Cell Signaling Technology Enters Into Licensing Agreement With Cepheid For Personalized Cancer Diagnostics 10
Ventana Medical Systems Enters Into Licensing Agreement With Cell Signaling Technology 11
NanoString Technologies Enters into Agreement with Cell Signaling Technology 12
Cell Signaling Technology Inc – Key Competitors 13
Cell Signaling Technology Inc – Key Employees 14
Cell Signaling Technology Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Strategy And Business Planning 16
Apr 05, 2018: Cell Signaling Technology Expands in China 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Cell Signaling Technology Inc, Medical Equipment, Key Facts 2
Cell Signaling Technology Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cell Signaling Technology Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cell Signaling Technology Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cell Signaling Technology Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cell Signaling Technology Inc, Deals By Market, 2012 to YTD 2018 8
Cell Signaling Technology Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cell Signaling Technology Enters Into Licensing Agreement With Cepheid For Personalized Cancer Diagnostics 10
Ventana Medical Systems Enters Into Licensing Agreement With Cell Signaling Technology 11
NanoString Technologies Enters into Agreement with Cell Signaling Technology 12
Cell Signaling Technology Inc, Key Competitors 13
Cell Signaling Technology Inc, Key Employees 14
Cell Signaling Technology Inc, Other Locations 15
Cell Signaling Technology Inc, Subsidiaries 15

List of Figures
Cell Signaling Technology Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cell Signaling Technology Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cell Signaling Technology Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cell Signaling Technology Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cell Signaling Technology Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cell Signaling Technology Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cell Signaling Technology Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cell Signaling Technology Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Luye Pharma Group Ltd (2186):企業の財務・戦略的SWOT分析
    Summary Luye Pharma Group Ltd (Luye Pharma Group) is a drug company that manufactures, develops, discovers, and commercializes novel formulations, natural drugs, medicinal products, pharmaceutical products, and biotechnology products. The group’s products include paclitaxel liposome, lentinan, sodiu …
  • CryoLife Inc (CRY):医療機器:M&Aディール及び事業提携情報
    Summary CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide dif …
  • Dangote Cement Plc:企業の戦略・SWOT・財務情報
    Dangote Cement Plc - Strategy, SWOT and Corporate Finance Report Summary Dangote Cement Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Alliant Energy Corp (LNT):電力:M&Aディール及び事業提携情報
    Summary Alliant Energy Corp (Alliant Energy) is an energy utility holding company. Through subsidiaries, it carries out generation and distribution of electricity and distribution and transportation of natural gas. The company operates through Interstate Power and Light Company (IPL) and Wisconsin P …
  • Zoll Medical Corporation:医療機器:M&Aディール及び事業提携情報
    Summary ZOLL Medical Corporation (Zoll), a subsidiary of Asahi Kasei Corporation, is a provider of medical devices and software solutions for advance emergency care. The company designs, manufactures and markets resuscitation devices and systems used for resuscitation and acute critical care victims …
  • Event Hospitality & Entertainment Ltd:企業の戦略・SWOT・財務分析
    Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report Summary Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • ICI Pakistan Ltd (ICI):企業の財務・戦略的SWOT分析
    ICI Pakistan Ltd (ICI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Olon SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Olon SpA (Olon), formerly Antibioticos SpA, a susbsidiary of P&R S.p.A. is a developer and producer of active pharmaceutical ingredients. The company offers products such as azacitidine, bezafibrate, ibuprofen sodium, acamprosate calcium, acebutolol hydrochloride, acitretin, thalidomide, aba …
  • Addvalue Technologies Limited (A31):企業の財務・戦略的SWOT分析
    Addvalue Technologies Limited (A31) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Mahaweli Reach Hotels Plc
    Mahaweli Reach Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary Mahaweli Reach Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Wells Fargo Private Bank:企業の戦略・SWOT・財務情報
    Wells Fargo Private Bank - Strategy, SWOT and Corporate Finance Report Summary Wells Fargo Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • McKinsey & Company, Inc.:企業の戦略・SWOT・財務情報
    McKinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary McKinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Heat Biologics Inc (HTBX)-製薬・医療分野:企業M&A・提携分析
    Summary Heat Biologics Inc (Heat Biologics) is an immuno-oncology company that develops novel therapies to activate patient’s immune system against cancer. The company develops immune pan-antigen cytotoxic therapy, which is a therapeutic vaccine used in the treatment of cancer and infectious disease …
  • GE Healthcare LLC-製薬・医療分野:企業M&A・提携分析
    Summary GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cell …
  • Inter RAO UES (IRAO):電力:M&Aディール及び事業提携情報
    Summary Inter RAO UES (Inter RAO) is a vertically integrated energy utility. It has presence in the energy value chain, including electricity generation, transmission, sales, trading and engineering. The company generates power in thermal, hydro, and co-generation plants; and supplies that energy on …
  • Advantage Oil & Gas Ltd. (AAV)-石油・ガス分野:企業M&A・提携分析
    Summary Advantage Oil & Gas Ltd. (Advantage Oil) is an upstream company that exploits, develops, acquires, and produces natural gas and liquids in Alberta. Its exploitation and development program is focused at Glacier. The company’s acreage is spread throughout the Western Canadian Sedimentary Basi …
  • Cabot Corp (CBT):企業の財務・戦略的SWOT分析
    Cabot Corp (CBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • UbiVac LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary UbiVac LLC (UbiVac) is a clinical stage immuno-oncology companythat offers immunotherapeutic products. The company offers research and development of therapeutic vaccines for the treatment of cancer and infectious diseases. Its pipeline product includes DPV-001, a DC-targeted complex vaccine …
  • Boise Cascade Co (BCC):企業の財務・戦略的SWOT分析
    Summary Boise Cascade Co (Boise Cascade) is engaged in the manufacture and distributor of wood products and building materials. The company's product portfolio include engineered wood, panels and lumber and building materials. Its building materials comprise concrete products, adhesive, gypsum, insu …
  • Dynasil Corporation of America (DYSL):企業の財務・戦略的SWOT分析
    Summary Dynasil Corporation of America (Dynasil) is an electronic equipment company that develops and manufactures optics and photonics products. The company’s products include beam splitters, bandpass filters, coatings, crystal materials, imaging detectors, diffraction gratings, tunable light sourc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆